Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Genkyotex

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Genkyotex (Euronext Paris and Brussels: GKTX) is the leading biopharmaceutical company developing NOX therapies. Its unique therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. Genkyotex’s platform enables the identification of orally available small-molecules that selectiv...
Genkyotex (Euronext Paris and Brussels: GKTX) is the leading biopharmaceutical company developing NOX therapies. Its unique therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. Genkyotex’s platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes. From this, Genkyotex is developing a pipeline of first-in-class product candidates targeting one or multiple NOX enzymes.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Genkyotex
France Flag
Country
Country
France
Address
Address
Forum 2 Archamps Technopole 218 avenue Marie Curie FR-74166 Saint-Julien- en-Genevois
Telephone
Telephone
+33 (0)5 61 28 70 60
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY